As has been reported in studies on diabetic nephropathy, the succinate-GPR91 pathway mediates the upregulation of MAPK, cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) (17,18). This evidence concerns the gene PTGS2 and diabetic kidney disease.